학술논문

An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial
Document Type
Article
Author
Bornstein, Natan MSaver, Jeffrey LDiener, Hans ChristophGorelick, Philip BShuaib, AshfaqSolberg, YoramThackeray, LisaSavic, MilanJanelidze, TamarZarqua, NatiaYarnitsky, DavidMolina, Carlos AShuaib, AshfaqHill, MichaelVaclavik, DanielSkoloudik, DavidFiksa, JanAndersen, GretheJakala, PekkaTatlisumak, TurgutKuzmanovski, IgorGuillon, BenoitChabriat, HuguesMahagne, Marie HeleneTimsit, SergeRonziere, ThomasIngorokva, GochaBeridze, MayaBeridze, MziaZarqua, NatiaKharaishvili, NinoKakabadze, NodarJanelidze, TamarGriewing, BerndHobohm, CarstenSchneider, DietmarWeimar, ChristianPoppert, HolgerKimmig, HubertBerrouschot, JoergRingleb, PeterSchwab, StefanKohrmann, MartinKallmunzer, BerndKollmar, RainerEndres, MatthiasHausler, Karl-GeorgCheung, RaymondWai Hong Leung, ThomasDorodnicov, ElenaHalevi, HenAuriel, EitanStreifler, JonathanLeker, RonenSchwammenthal, YvonneToni, DaniloAgnelli, GiancarloCaso, ValeriaSłowik, AgnieszkaCzlonkowska, AnnaLubinski, IgnacyKochanowicz, JanSobolewski, PiotrBrola, WaldemarSalgado, Antonio VascoCorreia, CarlosAzevedo, ElsaRoriz, JoseZarkov, MarijaSavic, MilanPetrovic, ZarkoKrastev, GeorgiDvorak, MiloslavRodriguez Campello, AnaNunez, Antonio GilMolina, CarlosPurroy, FranciscoMarti-Fabregas, JoanArenillas, JuanAlonso, MariaCardona, PedroBlanco Gonzalez, MiguelTur, SilviaSegura Martin, TomasAnzhelika, PayenokShownkeen, HarishConcha, MauricioSethi, PramodSen, SouvikZaidi, SyedZaidi, SyedDevlin, Thomas
Source
The Lancet; July 2019, Vol. 394 Issue: 10194 p219-229, 11p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Sphenopalatine ganglion stimulation increased cerebral collateral blood flow, stabilised the blood–brain barrier, and reduced infarct size, in preclinical models of acute ischaemic stroke, and showed potential benefit in a pilot randomised trial in humans. The pivotal ImpACT-24B trial aimed to determine whether sphenopalatine ganglion stimulation 8–24 h after acute ischaemic stroke improved functional outcome.